Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SYNTHETECH - NZYM -- Ignore unavailable to you. Want to Upgrade?

To: tuck who wrote (313)	1/24/2000 11:02:00 PM
From: Dan Gibbs	Read Replies (1) \| Respond to of 372

NZYM was up 27% ($1) on heavy volume of 264,000 shares today. I checked with the company and they don't seem to know why the stock would move so suddenly. Presumably someone decided to take a big position in a hurry. I don't think we'll hear any really exciting news for another 6-12 months, but it seems that there is a fairly broad base of drugs in development using NZYM products and at least a few of these should eventually progress on to FDA approval. In the short term, the 3rd quarter (ended Dec. 31) will probably come in at only a few cents per share as the company announced previously, but the 4th quarter should be better. I think (?hope) that we will see revenues and earnings really break out toward the end of fiscal 2001.